Welcome to the InfoSci Platform
Linkage between Efficiency of Assets Management and Profitability in Selected Companies in Pharmaceutical Industry

Linkage between Efficiency of Assets Management and Profitability in Selected Companies in Pharmaceutical Industry

Kaushik Chakraborty
Copyright: © 2014 |Pages: 15
ISBN13: 9781466651548|ISBN10: 1466651547|EISBN13: 9781466651555
DOI: 10.4018/978-1-4666-5154-8.ch015
Cite Chapter Cite Chapter

MLA

Chakraborty, Kaushik. "Linkage between Efficiency of Assets Management and Profitability in Selected Companies in Pharmaceutical Industry." Handbook of Research on Strategic Business Infrastructure Development and Contemporary Issues in Finance, edited by Nilanjan Ray and Kaushik Chakraborty, IGI Global, 2014, pp. 207-221. https://doi.org/10.4018/978-1-4666-5154-8.ch015

APA

Chakraborty, K. (2014). Linkage between Efficiency of Assets Management and Profitability in Selected Companies in Pharmaceutical Industry. In N. Ray & K. Chakraborty (Eds.), Handbook of Research on Strategic Business Infrastructure Development and Contemporary Issues in Finance (pp. 207-221). IGI Global. https://doi.org/10.4018/978-1-4666-5154-8.ch015

Chicago

Chakraborty, Kaushik. "Linkage between Efficiency of Assets Management and Profitability in Selected Companies in Pharmaceutical Industry." In Handbook of Research on Strategic Business Infrastructure Development and Contemporary Issues in Finance, edited by Nilanjan Ray and Kaushik Chakraborty, 207-221. Hershey, PA: IGI Global, 2014. https://doi.org/10.4018/978-1-4666-5154-8.ch015

Export Reference

Mendeley
Favorite

Abstract

This chapter empirically investigates the relationship between the efficiency of asset management and profitability of the Indian pharmaceutical industry during the period 2002-03 to 2011-12. The chapter also tries to make a comparison, in respect of the efficiency of assets management, between multinational and domestic companies in the Indian pharmaceutical industry during the same period. The sample size of the study consists of 20 pharmaceutical companies by taking 10 multinational and 10 domestic companies from the Indian pharmaceutical industry. The issues analyzed in this study have been tackled using relevant statistical tools and techniques.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.